<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1500">
 <bold>Results:</bold> a total of 133 patients were analyzed. The cure rates were similar (71.2 % vs 68.6 %, p = 0.85). AS administration was superior in improvement of the PaO2/FiO2 ratio during evolution. Also, it was faster in pathogen eradication (p = 0.04). In survivors, weaning of ventilation was significantly earlier in AS group: 13.8 vs 19 d (p = 0.01). No difference for secondary outcome measures (Table 
 <xref rid="Fig14" ref-type="fig">14</xref>)
</p>
